1. Home
  2. DOGZ vs ELTX Comparison

DOGZ vs ELTX Comparison

Compare DOGZ & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DOGZ

Dogness (International) Corporation

HOLD

Current Price

$1.45

Market Cap

153.5M

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$8.83

Market Cap

134.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOGZ
ELTX
Founded
2003
2011
Country
US
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
134.1M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
DOGZ
ELTX
Price
$1.45
$8.83
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
2.5M
133.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.94
EPS
N/A
N/A
Revenue
N/A
$2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$4.60
52 Week High
$34.53
$12.62

Technical Indicators

Market Signals
Indicator
DOGZ
ELTX
Relative Strength Index (RSI) 19.41 57.25
Support Level $1.10 $8.05
Resistance Level $1.53 $9.61
Average True Range (ATR) 0.23 0.81
MACD 0.21 0.07
Stochastic Oscillator 37.19 62.04

Price Performance

Historical Comparison
DOGZ
ELTX

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: